Comparing Adjuvanted H28 and Modified Vaccinia Virus Ankara Expressing H28 in a Mouse and a Non-Human Primate Tuberculosis Model

Open Access

Peer-reviewed

Research Article

Rolf Billeskov,

Affiliations Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark, Institute of International Health, Immunology and Microbiology, University of Copenhagen, Denmark
⨯
Jan P. Christensen,

Affiliation Institute of International Health, Immunology and Microbiology, University of Copenhagen, Denmark
⨯
Claus Aagaard,

Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark
⨯
Peter Andersen,

Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark
⨯
Jes Dietrich

* E-mail: jdi@ssi.dk

Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark
⨯

Reader Comments (0)

T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
T helper cells
Is the Subject Area "T helper cells" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.